Haploidentical Bone Marrow Transplantation

BIOLOGICAL2 trials

Conditions

Burkitt LymphomaLeukemia, Myeloid, AcuteLymphoma, B-CellLymphoma, FollicularLymphoma, Large B-Cell, DiffusePrecursor B-Cell Lymphoblastic Leukemia-LymphomaSickle Cell Disease

Phase 2

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

CompletedNCT00849147

Medical College of WisconsinBurkitt Lymphoma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell +3

Start: 2008-10-31End: 2013-11-30Updated: 2023-01-04

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

CompletedNCT03263559

Medical College of WisconsinSickle Cell Disease

Start: 2017-10-03End: 2025-01-29Updated: 2025-04-27

Blood2025-11-03

Haploidentical Bone Marrow Transplantation for Sickle Cell Disease

NEJM Evidence2025-02-2523 citations

Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease

Blood Advances2024-10-071 citations

Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.

2024-03-011 citations

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Blood2023-11-2112 citations

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507

Blood2019-11-131 citations

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

2011-04-28422 citations

Haploidentical Bone Marrow Transplantation

Sponsors

Conditions

Phase 2

Related Papers